FibroGen (FGEN)
NASDAQ:FGEN
Holding FGEN?
Track your performance easily

FibroGen (FGEN) Financial Statements

931 Followers

FibroGen Financial Overview

FibroGen's market cap is currently ―. The company's EPS TTM is $-1.706; its P/E ratio is -0.25; FibroGen is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 50.64M$ 55.90M$ 27.14M$ 40.13M$ 23.89M
Gross Profit$ 45.46M$ 30.15M$ 21.73M$ 35.89M$ 44.32M
EBIT$ -11.02M$ -28.49M$ -51.70M$ -59.19M$ -79.69M
EBITDA$ -8.95M$ -27.67M$ -49.82M$ -58.65M$ -78.10M
Net Income Common Stockholders$ -14.26M$ -32.93M$ -56.23M$ -67.91M$ -87.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 140.71M$ 177.60M$ 235.59M$ 251.34M$ 335.72M
Total Assets$ 293.20M$ 365.87M$ 423.53M$ 460.43M$ 515.13M
Total Debt$ 146.38M$ 149.96M$ 152.55M$ 153.59M$ 156.23M
Net Debt$ 5.67M$ -27.64M$ -83.04M$ -97.75M$ -179.48M
Total Liabilities$ 483.58M$ 552.02M$ 585.73M$ 575.63M$ 575.43M
Stockholders Equity$ -232.34M$ -228.12M$ -204.17M$ -157.17M$ -102.27M
Cash Flow-
Free Cash Flow$ -39.88M$ -59.32M$ -18.57M$ -85.22M$ -111.56M
Operating Cash Flow$ -39.87M$ -59.29M$ -18.32M$ -84.54M$ -110.57M
Investing Cash Flow$ 72.24M$ 51.28M$ 10.24M$ 54.22M$ -14.29M
Financing Cash Flow$ 32.00K$ -165.00K$ -246.00K$ -22.00K$ 91.53M
Currency in USD

FibroGen Earnings and Revenue History

FibroGen Debt to Assets

FibroGen Cash Flow

FibroGen Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis